2022 annual financial data
Ascendis Pharma 2022 Operating margin
Ascendis Pharma 2022 operating margin with verified reported values.
Direct answer
Operating margin was -1,097.85%.
Operating income was -561,814,000 EUR and net income was -583,194,000 EUR.
Operating cash flow was -495,699,000 EUR.
Get free Ascendis Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 51,174,000 EUR
- Operating income
- -561,814,000 EUR
- Net income
- -583,194,000 EUR
- Operating cash flow
- -495,699,000 EUR